ABSTRACT: Ectopic lipid storage in the liver is considered the main risk factor for nonalcoholic steatohepatitis (NASH). Understanding the molecular networks controlling hepatocellular lipid deposition is therefore essential for developing new strategies to effectively prevent and treat this complex disease. Here, we describe a new regulator of lipid partitioning in human hepatocytes: mammalian sterile 20-like (MST) 3. We found that MST3 protein coats lipid droplets in mouse and human liver cells. Knockdown of MST3 attenuated lipid accumulation in human hepatocytes by stimulating b-oxidation and triacylglycerol secretion while inhibiting fatty acid influx and lipid synthesis. We also observed that lipogenic gene expression and acetyl-coenzyme A carboxylase protein abundance were reduced in MST3-deficient hepatocytes, providing insight into the molecular mechanisms underlying the decreased lipid storage. Furthermore, MST3 expression was positively correlated with key features of NASH (i.e., hepatic lipid content, lobular inflammation, and hepatocellular ballooning) in human liver biopsies. In summary, our results reveal a role of MST3 in controlling the dynamic metabolic balance of liver lipid catabolism vs. lipid anabolism. Our findings highlight MST3 as a potential drug target for the prevention and treatment of NASH and related complex metabolic diseases.-Cansby, E., Kulkarni, N. M., Magnusson, E., Kurhe, Y., Amrutkar, M., Nerstedt, A., Ståhlman, M., Sihlbom, C., Marschall, H.-U., Borén, J., Blüher, M., Mahlapuu, M. Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans. FASEB J. 33, 9974-9989 (2019 The human kinome features a large branch of Ste20-type kinases, named after the founding member yeast Sterile20 kinase, which is involved in the mating pathway. Ste20 kinases are characterized by a high degree of homology in the catalytic domain, and they fall into the following 2 families: the p21-activated kinases (PAKs) with a C-terminal kinase domain and an N-terminal p21 GTPase-binding domain or the germinal center kinases (GCKs), which lack GTPase-binding domains and have an N-terminal kinase domain (1, 2). Ste20-type kinases are implicated in a wide range of biologic responses, such as regulation of cell proliferation and differentiation, polarity, stress responses, and cytoskeleton rearrangements (1, 2).
however, MST3 can be cleaved by caspases, which results in nuclear localization of its kinase domain and promotes apoptosis (5, 6) . MST3 regulates actin dynamics and cell migration in many contexts and has been implicated in cancer (7) (8) (9) as well as in the pathology of endothelial malformations (10) . Several studies have also found that MST3 plays important roles in the regulation of neuronal functions (11, 12) . Partial knockdown of MST3 has recently been shown to lower hyperglycemia and hyperinsulinaemia and to improve insulin sensitivity in mice fed a high-fat diet (13) . Interestingly, our previous studies have revealed that depletion of the closely related Ste20-type kinase STK25 in mice also protects against high-fat diet-induced glucose intolerance and insulin resistance and reduces both ectopic lipid storage and meta-inflammation in peripheral tissues prone to diabetic damage; of note, we observed the reciprocal phenotype in obese mice that overexpress STK25 (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) .
In this study, we identified MST3 by global proteomic analysis as a lipid droplet (LD)-associated protein in mouse liver. We further examined the effect of modifying MST3 expression levels on cellular lipid metabolism in human cultured hepatocytes. In agreement with our observation in mouse liver, we found that MST3 coats intracellular LDs in human hepatocytes, where it plays a role in lipid partitioning by modulating NEFA uptake and triacylglycerol (TAG) synthesis as well as b-oxidation and lipid secretion. Furthermore, we found a positive correlation between hepatic MST3 mRNA abundance and development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in humans.
NAFLD, defined as fatty infiltration in .5% of hepatocytes (steatosis) in the absence of excessive alcohol consumption, is emerging as a leading cause of liver disease worldwide (25) . In a subgroup of patients with NAFLD, the disease progresses to NASH, which, in addition to liver steatosis, is characterized by the presence of hepatic inflammation and cellular damage in the form of ballooning (25) . To date, there is no established validated therapy for NAFLD or NASH. Hence, understanding the molecular mechanisms controlling ectopic lipid storage in the liver and the transition from benign hepatic steatosis to NASH represents a major clinical challenge.
MATERIALS AND METHODS

Liquid chromatography mass spectrometry analysis of mouse liver LDs
From the age of 6 wk, 5 male mice of C57BL6/J strain were fed a pelleted high-fat diet (45% kilocalories from fat, D12451; Research Diets, New Brunswick, NJ, USA) for 18 wk. After 4 h of food withdrawal, mice were humanely killed. The livers were minced, resuspended in 4 ml of buffer A [25 mM tricene (MilliporeSigma, Burlington, MA, USA), 250 mM sucrose (MilliporeSigma), and protease inhibitor cocktail (Thermo Fisher Scientific, Waltham, MA, USA)], and dounce homogenized on ice followed by further homogenization using a needle and a syringe. After addition of 4 ml of buffer A, the postnuclear supernatant was divided into 2 ultracentrifuge tubes, overlaid with 3 ml buffer B (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 100 mM KCl, and 2 mM MgCl 2 ; MilliporeSigma), and centrifuged at 300,000 g for 1 h at 4°C. The LD-containing band was transferred into a fresh tube and centrifuged at 20,000 g for 20 min at 4°C. The underlying liquid was carefully removed, and the LD fraction was washed 4 times with buffer B to remove copurifying membranes (26, 27 ). The isolated LDs were then stored at 280°C until further analysis. Liquid chromatography mass spectrometry (LC-MS) of LD proteins was performed on an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific) interfaced with an Easy-nLC 1200 nanoflow liquid chromatography system (Thermo Fisher Scientific) as described in the Supplemental Materials and Methods.
Notably, we homogenized the whole mouse livers to provide a sufficient protein amount for LC-MS analysis, and histologic or biochemical characterization of liver tissue used for LD isolation has not been performed to assess the extent of diet-induced liver damage. However, in our previous study, we found that male mice of the same strain (i.e., C57BL6/J) fed an identical high-fat diet (i.e., 45% kilocalories from fat, D12451; Research Diets) for about 20 wk developed the total NAFLD activity score (NAS) of 3.0 6 0.2 (steatosis: 1.7 6 0.1, inflammation: 0.4 6 0.1, ballooning: 0.8 6 0.1), and plasma alanine aminotransferase and aspartate transaminase, which are markers of liver cell damage, measured 15.0 6 5.2 and 22.5 6 1.5 U/L, respectively (24) .
Culture of immortalized human hepatocytes
Immortalized human hepatocytes (IHHs; a gift from B. Staels, the Pasteur Institute of Lille, University of Lille Nord de France, Lille, France) (28) were maintained in William's E Medium (Gluta-MAX Supplemented; Thermo Fisher Scientific) supplemented with human insulin (20 U/L, Actarapid Penfill; Novo Nordisk, Bagsvaerd, Denmark), dexamethasone (50 nM; MilliporeSigma), 10% (vol/vol) fetal bovine serum (Thermo Fisher Scientific), and 1% (vol/vol) penicillin/streptomycin (Thermo Fisher Scientific). Cells were demonstrated to be free of mycoplasma infection by use of the MycoAlert Mycoplasma Detection Kit (Lonza, Basel, Switzerland).
RNA interference and transient overexpression
IHHs were transfected with MST3 small interfering (si) RNA (139160; Ambion, Austin, TX, USA) or scrambled siRNA (SIC001; MilliporeSigma) using Lipofectamine RNAiMax (Thermo Fisher Scientific). IHHs were also transfected with human influenza hemagglutinin (HA)-tagged MST3 (EX-T8396-M06; GeneCopoeia, Rockville, MD, USA) or an empty control plasmid (EX-NEG-M43; GeneCopoeia) using Lipofectamine 2000 (Thermo Fisher Scientific).
Lipid content, mitochondrial function, and oxidative stress in IHHs Cells were stained with Oil Red O for neutral lipids or MitoTracker Red (Thermo Fisher Scientific) for active mitochondria. For Oil Red O staining, IHHs cultured in 12-well plates were fixed for 20 min in 4% (vol/vol) phosphate-buffered formaldehyde and incubated with 0.5% (wt/vol) Oil Red O (MilliporeSigma) in 60% (vol/vol) isopropanol for 10 min at room temperature, followed by counterstaining with Mayer's hematoxylin (Histolab Products, Gothenburg, Sweden) for 1 min. The total number of LDs and LD size distribution were assessed in 10 randomly selected 203 fields/well in 4 wells/test condition using ImageJ software (v.1.47; National Institutes of Health, Bethesda, MD, USA). For mitochondrial staining, IHHs cultured in 4-well chamber slides were stained with 50 nM MitoTracker Red for 20 min at 37°C followed by fixation with 0.16% (vol/vol) phosphate-buffered formaldehyde for 15 min at 37°C and staining with DAPI (Thermo Fisher Scientific). The cover slip was mounted using Prolong Gold Antifade Mountant (Thermo Fisher Scientific). Mitochondrial area was assessed in 5 randomly selected 203 fields/well in 8 wells/test condition using ImageJ software.
Lipids were also extracted using the BUME method (29) and quantified using MS. The cholesteryl esters, TAGs, and phospholipids were quantified using direct infusion on a QTRAP 5500 mass spectrometer (Sciex, Concord, ON, Canada) equipped with a robotic nanoflow ion source, the TriVersa NanoMate (Advion BioSciences, Ithaca, NJ, USA), and ceramides were quantified using ultra-high performance LC-MS (30) .
Cells were processed for immunofluorescence with anti-MST3, anti-adipose differentiation-related protein (ADRP), anti-peroxisomal biogenesis factor 5 (PEX5), or anti-4-hydroxynonenal (HNE) antibodies (see Supplemental Table S1 for antibody information); the labeled area was quantified in 5 randomly selected microscopic fields (320)/well using ImageJ software.
Assessment of lipid anabolism and catabolism in IHHs
Fatty acid uptake was measured using the Supplemental Table S2 for custom-designed primer and probe sequences). Relative quantities of target transcripts were calculated after normalization of the data to the endogenous control, 18S rRNA (Thermo Fisher Scientific).
Analysis of liver biopsies from human participants
The expression of MST3 mRNA was measured in liver biopsies obtained from 62 white individuals (men, n = 35; women, n = 27) who underwent laparoscopic abdominal surgery for Roux-en-Y bypass (n = 12), sleeve gastrectomy (n = 9), or elective cholecystectomy (n = 41). Liver biopsy donors fulfilled the following inclusion criteria: 1) men and women, age . and/or antibodies against glutamic acid decarbosylase (GAD) and islet cell antibodies, 4) systolic blood pressure .140 mmHg and diastolic blood pressure .95 mmHg, 5) clinical evidence of either cardiovascular or peripheral artery disease, 6) thyroid dysfunction, 7) alcohol or drug abuse, and 8) pregnancy. Type 2 diabetes was defined according to the American Diabetes Association Criteria (32) by a fasting plasma glucose .7.0 mM and/or a 120 min oral glucose tolerance test glucose .11.1 mM. For participant characteristics, see Supplemental Table S3 .
Total body fat content was assessed by dual X-ray absorptiometry (DEXA) analysis. Liver fat was measured by single-proton magnetic resonance spectroscopy ( 1 H-MRS) for determination of hepatic fat fraction as previously described (33) (34) (35) . A small liver biopsy was taken during the surgery, immediately snap frozen in liquid nitrogen, and stored at 280°C until further preparations. All liver biopsies were collected between 8:00 and 1000 AM after food withdrawal overnight. NAS was assessed on liver sections by a certified pathologist, according to the scoring system described (36) . Quantitative real-time PCR assessment in liver biopsies was performed as described above using the probes for MST3 (Hs00269168_m1; Thermo Fisher Scientific) and 18S rRNA (Hs99999901_s1; Thermo Fisher Scientific), which span exon-exon boundaries to improve the specificity.
All participants gave their written informed consent before taking part in the study. All investigations were approved by the Ethics Committee of the University of Leipzig, Germany (159-12-21052012 and 017-12-23012012) and were performed in accordance with the Declaration of Helsinki.
Western blot
Western blot was performed as previously described in Cansby et al. (14) (see Supplemental Table S1 for antibody information).
Statistical analysis
Statistical significance between the groups was evaluated using the 2-sample Student's t test and among .2 groups by 2-way ANOVA followed by a 2-sample Student's t test for post hoc analysis, with a value of P , 0.05 considered statistically significant. The median difference in LD size between the groups was examined using an independent sample median test. The relationship between MST3 expression in human liver and hepatic fat content measured by MRS, inflammation, and total NAS was assessed by Spearman's rank correlation; the relationship between MST3 expression and histologic steatosis and ballooning in the liver, for which the majority or all subjects were in only 2 score categories, was quantified by the coefficient of determination for ANOVA models. Prior to correlation analysis, the Kolmogorov-Smirnov test was used to assess normality of data on the original scale. All the reported P values are unadjusted for multiplicity. All statistical analyses were performed using SPSS statistics (v.24; IBM SPSS, Chicago, IL, USA).
RESULTS
Protein kinase MST3 is associated with LDs in mouse liver
To identify novel constituents of the hepatic LD proteome, we performed global proteomic analysis by LC-MS technique in LDs isolated by sucrose gradient centrifugation (27) from the livers of high-fat diet-fed mice of C57BL6/J strain. In total, we identified 4513 proteins in the liver LD fraction of high-fat-fed mice (Supplemental Table S4 ). The LD preparation contained several expected bona-fide LD marker proteins such as ADRP (also known as perilipin-2 or adipophilin), PNPLA2 (also known as ATGL), ABHD5 (also known as CGI-58), CIDEB, CES3, and RAB7. One of the proteins identified in the LD fraction was the Ste20-type kinase STK25, which, based on our recent studies, has emerged as a liver LD-coating protein and a critical regulator of hepatic LD dynamics (15-18, 21, 24) . Interestingly, we also found that the closely related Ste20-type kinase MST3 was present in the LD fraction from all the 5 mice studied. MST3 has not previously been reported to localize to the LDs or to play a role in regulation of liver LD biology. The close homology between STK25 and MST3 prompted us to focus on studying the possible role of MST3 in hepatocyte lipid metabolism.
Notably, MST3 or STK25 were not found in the 2 recent proteomic studies performed on LDs isolated from mouse liver homogenates (37, 38) . This is likely linked to the difference in instrumentation; compared with the instruments used in these previous reports for LC-MS analysis [Velos Orbitrap (37) or LTQ XL mass spectrometer (38) ], the instrument used in our study (Orbitrap Fusion Tribrid mass spectrometer) is faster in data acquisition with higher MSn scanning rates, wide dynamic range, and ultrahigh mass resolution, which provides a higher sensitivity when detecting peptides with low abundance.
Importantly, morphologic studies have shown LDs in close proximity to, and interacting with, several membrane-bound cellular organelles, including the endoplasmatic reticulum (ER), mitochondria, peroxisomes, and endosomes; because of these close associations, it is difficult to purify LDs to homogeneity (39, 40) . Consistently, the LD fraction prepared by the isolation protocol used in this study is known to yield some contaminant proteins, although it has been shown to be highly enriched with LD-resident proteins (27, 37) . In line with the previous reports, we also detected a set of well-known marker proteins for peroxisomes (catalase and ACOX1), mitochondria (core catalytic components of mitochondrial electron transport chain complexes and ATP synthase), and endoplasmic reticulum [GRP78 (also known as BIP) and different isoforms of protein disulfide isomerase (PDI)] in the LD preparation. Because of difficulties to distinguish between bona-fide LD proteins and contaminant proteins in the proteomic analysis, we decided to further study the subcellular localization of our protein of interest MST3 by immunofluorescence microscopy with anti-MST3 antibody in liver sections collected from mice after high-fat feeding. We found that MST3 fully colocalized with ADRP, the main LD-coating protein in mouse liver (41) , confirming that MST3 is present on the surface of LDs, lining both large and small droplets, with the majority of droplets showing positive staining (Fig. 1A) . Notably, ADRP protein only exists in cells bound to LDs because in the absence of LD binding, ADRP is rapidly degraded via the ubiquitin-proteasome system (42, 43) . Thus, our observation that immunostaining for MST3 in liver sections fully colocalized with the immunostaining for ADRP (Fig. 1A) suggests that the subcellular localization of MST3 is essentially restricted to LDs. Consistently, no MST3 protein was detected in the cytosolic fraction of the liver LD preparation by Western blot analysis (unpublished results).
Next, we determined the relative expression of MST3 mRNA in human, mouse, and rat by quantitative real-time PCR. Similar to previous reports describing ubiquitous distribution of MST3 transcript in human tissues (3, 44) , we identified MST3 mRNA in all tissues examined in human, mouse, and rat (Fig. 1B) . The Western blot analysis in mice also detected MST3 protein in all tissues studied; consistently with mRNA analysis, the highest level of MST3 protein was seen in the samples from spleen (Fig. 1C) . Although our experiments described above clearly localized MST3 protein to LDs in mouse liver, high mRNA and protein expression of MST3 in organs that do not accumulate significant amounts of intracellular LDs raises the possibility that MST3 exists in different intracellular compartments in tissues other than liver.
Depletion of MST3 suppresses ectopic lipid accumulation in human hepatocytes
To investigate the possible impact of MST3 on lipid metabolism in human hepatocytes, we transfected IHHs with MST3-specific siRNA or with a nontargeting control (NTC) siRNA. In cells transfected with MST3 siRNA, the target mRNA expression was repressed by ;90% (Fig. 2A) , whereas the protein abundance of MST3 was below the detection limit of Western blot (Fig. 2B) . Notably, we found that the depletion of MST3 in IHHs did not result in any compensatory increase in the protein levels of the 2 closely related Ste20-type kinases, MST4 or STK25 (Fig. 2B ). Similar to our findings in mouse liver (Fig. 1A) , immunofluorescence analysis identified MST3 mainly on the surface of LDs, where it fully colocalized with ADRP, when we analyzed IHHs transfected with NTC siRNA; no MST3 staining was detected in cells transfected with MST3 siRNA (Fig. 2C) .
To analyze lipid deposition, we stained transfected IHHs with Oil Red O, which detects neutral lipids. Before staining, we also exposed cells to oleic acid, known to efficiently induce steatosis in vitro (45) (46) (47) (48) (49) , in order to mimic conditions in high-risk individuals. Notably, the protein level of MST3, as well as the protein abundance of MST4 and STK25, was similar in IHHs under basal cell culture conditions and when challenged with oleic acid (Fig. 2B) . Morphometric analysis of Oil Red O-stained cells revealed that MST3 knockdown markedly decreased the total number of intracellular LDs compared with cells transfected with NTC siRNA (Fig. 2D, E) . We found no difference in the median LD size comparing cells transfected with MST3 siRNA vs. NTC siRNA ( Supplemental Fig. S1A) ; however, the loss of a small fraction of very large LDs (.60 mm 2 ) was observed in MST3-deficient hepatocytes (Fig. 2F) . Lipidomic analysis confirmed reduced accumulation of cholesteryl esters, TAGs, lysophosphatidylcholines, and ceramides in IHHs transfected with MST3 siRNA compared with NTC siRNA, both under basal conditions and after supplementation with oleic acid, whereas reduced levels of phosphatidylcholines and phosphatidylethanolamines were observed by MST3 knockdown only in cells challenged with oleic acid (Fig.  2G and Supplemental Fig. S2 ). Analysis of individual TAG species demonstrated that depletion of MST3 suppressed the levels of all the main TAG species composed of both saturated and unsaturated fatty acids (Supplemental Fig. S3 and Supplemental Table S5 ).
Overexpression of MST3 aggravates intrahepatocellular lipid accumulation
To elucidate whether the increased MST3 abundance in human hepatocytes leads to a reciprocal effect compared with MST3 knockdown (i.e., aggravated lipid storage), we transfected IHHs with human MST3 expression plasmid or empty control plasmid. Cells transfected with MST3 expression plasmid had substantially higher MST3 mRNA and protein abundance (Fig. 3A, B) . Immunofluorescence analysis also revealed that, similar to the endogenous protein, overexpressed MST3 was targeted to the LDs visualized by ADRP staining (Fig. 3C) . Notably, we detected .100-fold increase in MST3 mRNA levels in cells transfected with MST3 expression plasmid compared with empty control plasmid (Fig. 3A) , whereas MST3 protein abundance was increased only about 2-fold (Fig. 3B) . The MST3 expression plasmid used in this study has the open reading frame downstream of the very potent cytomegalovirus (CMV) promoter and upstream of the simian virus 40 (SV40) poly-A signal, where the poly-A part contains a small intron from SV40 (50) . This context, where the termination codon of the open reading frame is situated upstream of the most 39 splice site, is known to induce nonsense-mediated mRNA decay, which leads to degradation of the mRNA at the point of export from the nucleus (51). Thus, nonsense-mediated mRNA decay is the likely explanation for discrepancy comparing MST3 mRNA and protein levels.
Morphometric analysis of Oil Red O-stained IHHs performed in cells challenged by oleic acid revealed a marked increase in the total number of intracellular LDs and a shift in the overall LD size distribution toward larger droplets in MST3-overexpressing hepatocytes (Fig. 3D-F   Figure 1 . MST3 is a broadly expressed kinase, which coats intracellular LDs in mouse liver. A) Representative immunofluorescence images of liver sections from high-fat diet-fed mice double-stained with antibodies for MST3 (green) and ADRP (red); merged image shows colocalization in yellow with nuclei stained with DAPI (blue) Supplemental Fig. S1B ). Lipidomic analysis also demonstrated enhanced accumulation of cholesteryl esters, TAGs, lysophosphatidylcholines, phosphatidylcholines, and phosphatidylethanolamines in IHHs transfected with MST3 expression plasmid compared with vector control; notably, a significant increase in these groups of lipids was observed only after supplementation with oleic acid and not under basal conditions ( Fig. 3G and Supplemental Figs. S4 and S5 and Supplemental Table S6 ).
Knockdown of MST3 in human hepatocytes suppresses LD anabolism through repressed fatty acid uptake and lipid synthesis and promotes LD catabolism through increased b-oxidation and TAG secretion Protection against intrahepatocellular lipid accumulation is of high medical relevance because ectopic lipid storage in the liver (i.e., liver steatosis) is a known risk factor for NASH (25) . Based on this evidence, we next investigated the mechanisms underlying the suppression of lipid accumulation by MST3 knockdown in human hepatocytes.
Conceptually, reduced intracellular lipid storage in IHHs transfected with MST3 siRNA vs. NTC siRNA could be caused by suppressed rate of free fatty acid uptake and lipid synthesis from one side (input) or increased b-oxidation and TAG export on the other side (output), or any combination of these mechanisms. Indeed, we found that fatty acid influx was lower at all time points measured in cells transfected with MST3 siRNA compared with NTC siRNA (Fig. 4A) . Furthermore, the incorporation of medium-derived [ (Fig. 4B, C) . Notably, we found no difference in the uptake of radiolabeled glucose in IHHs transfected with MST3 siRNA vs. NTC siRNA (Supplemental Fig. S6) .
In contrast to reduced fatty acid uptake and lipid synthesis, the secretion of de novo synthesized TAGs into the medium was significantly higher in cells transfected with MST3 siRNA compared with NTC siRNA (Fig. 4D) . To assess b-oxidation, we incubated IHHs in the presence of [9,10- ]-labeled water as the product of free fatty acid oxidation; we found that silencing of MST3 mediated by siRNA resulted in a significant increase in b-oxidation rate (Fig. 4E) . Consistently, staining with MitoTracker Red, a fluorescent dye that specifically accumulates within respiring mitochondria, was 3.4 6 0.3-fold higher in MST3-deficient hepatocytes (Fig. 5A) .
Impairment in hepatocyte mitochondrial function is one of the key mechanisms implicated in aggravated hepatic oxidative stress observed in metabolic liver disease NASH; furthermore, as the mitochondrial oxidative capacity decreases, extramitochondrial fatty acid oxidation in the peroxisomes takes over, which further escalates liver oxidative damage (25, (52) (53) (54) . Interestingly, we found that immunostaining for peroxisome biogenesis marker PEX5 was 1.8 6 0.3-fold reduced in MST3-deficient IHHs (Fig.  5B) , suggesting that improved mitochondrial function was indeed accompanied by lower peroxisomal activity. Consistently, the staining for 4-HNE, an end product of peroxidation of membrane N-6-polyunsaturated fatty acids and considered a reliable biomarker of oxidative stress in hepatocytes, was 2.3 6 0.2-fold lower in IHHs transfected with MST3 siRNA compared with NTC siRNA (Fig. 5C) .
Because of its subcellular localization, we hypothesized that MST3 may regulate lipid catabolism by controlling the release of fatty acids from intrahepatocellular LDs. Indeed, 3 H]triolein as the substrate. G) Cell viability assessed using resazurin. For B-G, cells were incubated with oleic acid for 48 hours; for A, cells were analyzed both under basal conditions and after supplementation with oleic acid. OA, oleic acid. Results are means 6 SEM from 7 to 10 wells/test condition. *P , 0.05, **P , 0.01 comparing cells transfected with MST3 siRNA vs. NTC siRNA.
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we found that TAG hydrolase activity measured using [ 3 H]triolein as the substrate was 2.1 6 0.4-fold higher in IHHs transfected with MST3 siRNA (Fig. 4F) . Notably, the cell viability assessed by measuring the conversion of resazurin to a fluorescent product resorufin within viable cells was not altered in MST3-deficient cells (Fig. 4G) .
Reduced lipogenic gene expression and acetyl-coenzyme A carboxylase protein abundance in MST3-deficient hepatocytes
Because MST3 knockdown effectively protected against lipid accumulation in hepatocytes, we next examined the expression of a set of genes involved in lipogenesis in IHHs transfected with MST3 siRNA vs. NTC siRNA. We found that the mRNA levels of CD36, critical for fatty acid influx into hepatocytes, fatty acid synthase (FASN) and acetyl-CoA carboxylase (ACC) 1 controlling de novo fatty acid synthesis, and glycerol-3-phosphate acyltransferase (GPAM) and diglyceride acyltransferase (DGAT2) catalyzing the committing steps in TAG biosynthesis were significantly lower in MST3-deficient cells, along with reduced mRNA abundance of lipogenic transcription factor carbohydrate-responsive element-binding protein (CHREBP) (Fig. 6A) . Of the examined targets involved in lipid oxidation, the mRNA expression of carnitine palmitoyltransferase I (CPT1), which controls long-chain fatty acyl-CoA uptake in mitochondria, and peroxisome proliferator activated receptor-a (PPARa), a transcriptional activator of b-oxidation in the liver, was significantly increased in IHHs transfected with MST3 siRNA vs. NTC siRNA (Fig. 6B) . Notably, the mRNA expression of glucose transporter 1 (GLUT1), the main glucose transporter in hepatocytes, was 2.3 6 0.1-fold higher in MST3-deficient IHHs, whereas the mRNA levels of glucose-6-phosphatase catalytic-subunit (G6PC), an enzyme regulating hepatic gluconeogenesis, were 3.0 6 0.7-fold lower (Fig. 6C) .
Interestingly, in addition to reduced oxidative stress (Fig. 5C ), we also found that the mRNA levels of the major indicators of ER stress CHOP (also known as DDIT3) and BIP (also known as HSP5A or GRP78) were significantly lower in IHHs transfected with MST3 siRNA compared with NTC siRNA (Fig. 6D) . Increased hepatocyte apoptosis, possibly accelerated by oxidative and ER stress, may distinguish NASH from isolated steatosis, and the protection against hepatocyte apoptosis could play a role in controlling the development of NASH (55) . Notably, the mRNA expression of proapoptotic markers BAX and caspase 1 and 3 (CASP1 and CASP3) was significantly lower in MST3-deficient hepatocytes, whereas the mRNA abundance of antiapoptotic protein BCL2, which is shown to be inversely correlated with the degree of apoptosis in NASH patients (55), was higher (Fig. 6E) . We found that the protein abundance of the both ACC isoforms was several-fold lower in IHHs transfected with MST3 siRNA vs. NTC siRNA (3.8 6 0.4-and 2.6 6 0.3-fold reduction in ACC1 and ACC2, respectively), whereas we did not detect any statistically significant difference in the ratio of phosphorylated ACC (inactive form) to ACC (Fig. 7A) . Cytosolic malonyl-CoA produced by ACC1 is used primarily as substrate for fatty acid biosynthesis; in contrast, malonyl-CoA produced by ACC2 allosterically inhibits mitochondrial fatty acid transporter CPT1 (56) . Reduction in ACC1 and ACC2 levels by MST3 knockdown is thus expected to reprogram hepatocyte metabolism, leading to reduced fatty acid synthesis and increased mitochondrial b-oxidation. We also detected a slight but significant reduction (1.3 6 0.1-fold) in ADRP protein levels in MST3-deficient hepatocytes (Fig. 7B) . Notably, suppression of ADRP abundance in the liver has been previously shown to prevent hepatic steatosis (41, (57) (58) (59) .
Expression of hepatic MST3 mRNA is positively correlated with liver fat content and NASH features in humans
We examined the expression of MST3 mRNA in relation to the hepatic fat content in liver biopsy material collected from 62 individuals with a wide range of BMI (22.7-45.6 kg/m 2 ), body fat (19.5-57.9%), and liver fat content (1.1-50.0%). Hepatic MST3 mRNA correlated significantly and positively with liver fat measured by 1 H-MRS (Fig.  8A) . There was no correlation between liver MST3 mRNA and the BMI, body fat content, or waist-to-hip ratio of the participants (Supplemental Fig. S7 ), indicating that the increase in hepatic MST3 expression was not a consequence of obesity.
Increased liver fat storage is considered the main risk factor for development of NASH (25) . We therefore further analyzed the correlation between hepatic MST3 expression and the main features used in today's clinical Figure 6 . Measurement of mRNA expression of selected genes controlling lipid synthesis (A) and oxidation (B) as well as glucose metabolism (C ), ER stress (D), and apoptosis (E ). IHHs were transfected with MST3 siRNA or NTC siRNA and challenged with oleic acid for 48 h. Relative mRNA expression was assessed by quantitative real-time PCR. Results are means 6 SEM from 8 wells/ test condition except for CPT1, CHOP, and BIP expression, for which n = 6-8. *P , 0.05, **P , 0.01 comparing cells transfected with MST3 siRNA vs. NTC siRNA.
diagnosis of NASH, liver inflammation and ballooning, by applying a widely used semiquantitative histologic scoring NAS (36) . In order to avoid bias, we limited all the correlation analyses between MST3 mRNA levels and the histologic components of the NAS to subjects with NAFLD (steatosis grade of 1 or higher; n = 47). MST3 mRNA correlated significantly and positively with lobular inflammation and hepatocellular ballooning as well as total NAS (Fig. 8B, C) . Furthermore, we found 2.3 6 0.4-fold increase in MST3 mRNA expression in the patients subset with a relatively higher total NAS (NAS = 5-8; n = 24) compared with a subset of relatively lower total NAS (NAS = 3-4; n = 23) (Fig. 8D) . Compared with the previous reports (60, 61) , a relatively higher percentage of subjects in this cohort had NAS .4 (51% of subjects with NAFLD had NAS = 5-8). Importantly, the samples were collected at a tertiary bariatric center, and this might induce a selection bias toward the more severe obesity cases regarding the number and severity of comorbidities. Notably, 43% of the patients with NAFLD in this study were diagnosed with type 2 diabetes, which has the potential to promote the progression to NASH (25) .
It should be emphasized that liver biopsies contain not only hepatocytes but also several types of inflammatory cells. In case the expression levels of MST3 would be different in these different cell populations, this may have contributed to the strong association observed between MST3 mRNA and liver inflammation (Fig. 8B) .
DISCUSSION
This study provides the first evidence to support a role for protein kinase MST3 in controlling lipid partitioning in human liver. First, we found that siRNA knockdown of Figure 7 . Repression of MST3 levels in human hepatocytes suppresses ACC and ADRP protein abundance. IHHs were transfected with MST3 siRNA or NTC siRNA and challenged with oleic acid for 48 h. Cell lysates were analyzed by Western blot using antibodies specific for ACC1, ACC2, ACC1/2, phosphorylated ACC1/2 (Ser79) (A), or ADRP (B). Representative Western blots are shown with actin used as a loading control. Protein levels were analyzed by densitometry, and data are shown as the protein abundance for ACC1, ACC2, ADRP, and the ratio of phosphorylated ACC to total ACC. Results are means 6 SEM from 8 to 12 wells/test condition. *P , 0.05, **P , 0.01 comparing cells transfected with MST3 siRNA vs. NTC siRNA.
MST3 in cultured human hepatocytes attenuated the accumulation of main lipids responsible for hepatic steatosis, TAGs and cholesteryl esters, in intracellular LDs. Conversely, the overexpression of MST3 in human hepatocytes aggravated lipid storage, resulting in increased number and size of intracellular LDs. Furthermore, we observed a positive correlation between hepatic MST3 mRNA expression and liver fat content quantified by MRS in human subjects.
Interestingly, we found that MST3 protein was mainly localized on the surface of intracellular LDs in both mouse liver and human hepatocytes. Once thought to be only inert energy storage depots, hepatic LDs are increasingly recognized as complex organelles that play a key role in the regulation of liver lipid partitioning and metabolic dysfunction, although the molecular mechanisms controlling hepatocyte LD dynamics still remain elusive (62, 63) . Through lipolysis mediated by several LD-associated lipases, the intrahepatocellular LDs provide a substrate for mitochondrial b-oxidation and secretion of very-lowdensity lipoprotein (VLDL)-TAG (62, 63) , and numerous lines of evidence suggest that impaired lipolysis in hepatocytes aggravates TAG accumulation in LDs (64, 65) . Lipid synthesis can also be regulated locally in LDs as the enzymes for TAG and phospholipid synthesis relocalize from the ER to the LD surface during the growth of the droplets (66) . Liver steatosis can then result either from increased hepatocyte LD anabolism (de novo lipogenesis and TAG synthesis) or decreased LD catabolism (fatty acid oxidation and lipid secretion) (63) . Notably, we found enhanced rate of lipolysis, b-oxidation, and TAG secretion in MST3-deficient hepatocytes, combined with inhibited fatty acid uptake and TAG synthesis, which provides a likely explanation for attenuated lipid accumulation observed with MST3 knockdown (Fig. 9) .
Based on the presence of MST3 on intrahepatocellular LDs, it is attractive to hypothesize that this kinase regulates liver lipid homeostasis locally by regulating the activity, abundance, or subcellular localization of other LD-associated enzymes directly involved in lipid metabolism. However, global proteomic analyses presented in this study as well as reports by other research groups (37, 38) reveal that the majority of proteins associated with LDs are not directly involved in neutral lipid metabolism but serve other complex functions such as cell signaling, membrane trafficking, and transcriptional control. Consistently, we found significant and coordinated changes in the mRNA expression profile of several lipogenic enzymes in MST3-deficient hepatocytes, which suggests that MST3 modulates liver lipid partitioning at least in part through transcriptional control.
Lipid accumulation in hepatocytes is considered the main risk factor for NASH, which is characterized by liver inflammation and hepatocellular injury (hallmarked by the presence of hepatocyte ballooning), in addition to fatty infiltration (25) . Notably, increased liver fat per se is not sufficient to trigger NASH, and imposition of additional signals, such as elevated hepatic oxidative stress, is required for progression from simple liver steatosis to NASH (52, 67) . Interestingly, we found that MST3 mRNA expression in human liver biopsies correlated significantly and positively with the main features of NASH (i.e., lobular inflammation and hepatocellular ballooning). Furthermore, we observed suppressed or aggravated oxidative stress in human cultured hepatocytes with reduced or increased MST3 The relationship between MST3 expression and hepatic fat content measured by MRS, inflammation, and total NAS was assessed by Spearman's rank correlation; the relationship between MST3 expression and histologic steatosis and ballooning was quantified by the coefficient of determination for ANOVA models. Because of evidence of nonnormality, the noncategorical variables [MST3 (RQ) and liver fat (%)] were log-transformed prior to analysis. RQ, relative quantification. Results are means 6 SEM.
abundance, respectively (Supplemental Fig. S8 ). Taken together, these data suggest that MST3 may control development of NASH by having an impact on both liver steatosis and hepatocellular oxidative injury.
Importantly, patients with NASH are at high risk of progression to liver fibrosis and cirrhosis, and NASH is also emerging as a dominant cause of hepatocellular carcinoma (68) . There is currently no effective pharmacotherapy approved for NASH, which has been recognized as one of the major unmet medical needs of the 21st century (69, 70) . The results of this study indicate that further investigations are warranted to understand whether depletion of MST3 provides protection against the development and progression of NASH in vivo. Additional studies are also needed to examine whether the decrease in neutral lipid storage in MST3-deficient hepatocytes has any risk to trigger a lipotoxic stress pathway or lead to liver injury (63) .
The role of MST3 in alteration of intrahepatocellular lipid storage described in this study is similar to the previously reported function of STK25, a closely related protein in the GCKIII subfamily of Ste20 kinases. Similar to MST3, STK25 protein is associated with hepatic LDs (16, 18) . Furthermore, STK25 knockdown attenuates lipid accumulation in human hepatocytes and mouse liver by repressing lipid synthesis and enhancing b-oxidation and VLDL-TAG secretion, and the reciprocal phenotype is seen when STK25 protein is overexpressed (15-18, 21, 24) . Similar to our findings in MST3-deficient human hepatocytes, our previous studies also reveal lower hepatic ACC levels in Stk25 knockout mice as well as in mice treated with Stk25 antisense oligonucleotides (15, 21, 24) . Even though the localization and function of MST3 and STK25 in liver cells partly overlap and they share high sequence homology, the results of this study clearly show that the presence of STK25 in human hepatocytes cannot compensate for the loss of MST3 in control of lipid homeostasis.
In summary, our results reveal a role of MST3 in the control of liver lipid partitioning by altering the dynamic metabolic balance of lipid catabolism vs. lipid anabolism in hepatocytes. Though our data provide a novel insight into the function of MST3 in hepatic LD dynamics, further studies are needed to fully characterize the mechanism of action of MST3 and its molecular substrates in hepatocytes. These findings also indicate that further investigations of MST3 as a potential therapeutic target for NASH are warranted. Marschall provided expertise and key reagents and contributed to the discussion; M. Mahlapuu directed the project, designed the study, interpreted the data, and wrote the manuscript; and all the authors revised the article critically for important intellectual content and approved the final version of the article to be published.
